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ABSTRACT 
 
Background: The use of advance care planning and advance decisions for psychiatric care is 
growing.  However, there is limited guidance on clinical management when a patient 
presents with suicidal behaviour and an advance decision and no systematic reviews of the 
extant literature. 
  
Objectives: To synthesise existing literature on the management of advance decisions and 
suicidal behaviour.   
 
Design: A systematic search of 7 bibliographic databases was conducted to identify studies 
relating to advance decisions and suicidal behaviour. Studies on terminal illness or end of 
life care were excluded to focus on the use of advance decisions in the context of suicidal 
behaviour. A textual synthesis of data was conducted and themes were identified by using 
an adapted thematic framework analysis approach.  
 
Results: Overall 634 articles were identified, of which 35 were retained for full text 
screening. Fifteen relevant articles were identified following screening. Those articles 
pertained to actual clinical cases or fictional scenarios. Clinical practice and rationale for 
management decisions varied. Five themes were identified: 1) tension between patient 
autonomy and protecting a vulnerable person, 2) appropriateness of advance decisions for 
suicidal behaviour, 3) uncertainty about the application of legislation, 4) the length of time 
needed to consider all the evidence vs. rapid decision-making for treatment, and 5) 
importance of seeking support and sharing decision-making. 
 
Conclusions: Advance decisions present particular challenges for clinicians when associated 
with suicidal behaviour. Recommendations for practice and supervision for clinicians may 
help to reduce the variation in clinical practice.   
 
Keywords: self-harm, suicidal behaviour, advance directives, advance decisions, living wills, 
Ulysses directives  
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Article Summary 
 
Strengths and limitations of this study 
• Timely systematic review considering the challenges relating to advance decisions in 
the context of suicidal behaviour 
• Review involves journal articles from a variety of countries from a range of 
disciplines 
• Paucity of evidence for this specific presentation of advance decision 
• Evidence in this area is predominately from reviews of case studies, rather than 
empirical work 
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INTRODUCTION 
 
An advance decision (sometimes known as an advance decision to refuse treatment (ADRT) 
or living will) is typically a written document that outlines a person’s desire to refuse certain 
treatments, including life-saving treatment, when there is a potential for a person to lose the 
mental capacity to make treatment decisions in the future.[1] In order for an advance decision 
to be valid, the person must have mental capacity at the time of writing the document. Mental 
capacity is defined as the ability to make a decision and involves understanding and weighing 
information relating to a decision and alternative options and retaining that information long 
enough to make the decision.[1] The Mental Capacity Act in England and Wales refers to 
“advance decisions to refuse treatment (ADRT),” but more widely these documents are 
referred to as “advance directives” and/or “living wills”. We use “advance decision” 
throughout in this paper to refer to written documents stating a refusal of treatment made 
in advance of medical treatment following an illness or injury. 
 
There are important cross-national variations in legislation; in some countries, the use of 
advance decisions is not permitted (i.e. Turkey, Japan), while in others, advance decisions are 
legislated for (i.e. the UK and US).  The UK, Australia and US have similar legal standards with 
some state-wide variation in the US and Australia,[2] with some states adopting the common 
law right to make an advance decision and others allowing the use of a surrogate or proxy 
decision maker (i.e. to make healthcare decisions on behalf of the patient). There is also 
considerable variation in practice between countries where advance decisions are permitted. 
For example, in Germany, advance decisions are recognised but require court approval in 
each case.[2]   
 
Advance care planning for psychiatric care is becoming more common in a number of 
countries, including the UK, US and Australia[3, 4] and enables patients to state their 
preferences for the management of their mental health condition when they may temporarily 
lose their mental capacity. A person with a mental health condition may also make some 
decisions about particular treatment that they would not wish to have and may involve an 
advance decision to refuse particular treatments, i.e. electroconvulsive therapy. Advance care 
planning has been shown to have a number of healthcare benefits for mental health patients 
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in the UK and US, such as enhancing patient autonomy and engagement, promoting 
adherence to treatment plans (i.e. patients taking prescribed drugs), improving continuity of 
care with fewer psychiatric admissions, reducing the use of social workers’ time and lower 
levels of violent acts.[3,4] In a recent survey of patients with bipolar disorder, 21% had written 
statements about their healthcare, and of those, 10% involved an advance decision to refuse 
treatment.[5] This increasing use of advance care planning in mental health may result in an 
increasing use of advance decisions to refuse mental health care treatment, and concerns 
about clinical management of advance decisions following suicidal behaviour have been made 
by healthcare professionals and legal and ethical consultants.[6-8] Existing literature, from a 
variety of academic and clinical perspectives, suggests there is little consistency in practice 
and there are specific challenges with advance decisions following suicidal behaviour. Such 
scenarios raise questions about whether a person with a wish to end their life has the capacity 
to make a decision about refusal of treatment and/or if their capacity is affected by mental 
illness, and whether an advance decision is appropriate for medical treatment following 
suicidal behaviour.[8] 
 
The terminology for suicidal behaviour varies internationally. Some clinicians/researchers 
distinguish between suicide attempts and non-suicidal self-injury[9, while others prefer the 
broad term of self-harm to denote behaviours across the spectrum.[1, 10]  We have taken an 
inclusive approach in this review to ensure we captured relevant studies, so in this review we 
refer to “suicidal behaviour” as behaviours including all self-harming behaviour (including 
non-suicidal injury) and suicide attempts. The use of “suicidal behaviour” in our review means 
that there may be cases of non-suicidal injury that may be included. 
 
The management of suicidal behaviour is a significant challenge for clinicians in the 
emergency services. Each year over 200,000 people present to emergency departments in 
England with self-harm,[10] with 16% of those presenting to hospital with a repeat self-harm 
episode within a year.[11] Treatment refusal following suicidal behaviour has been shown to 
be common. A prospective cohort study of mental capacity and suicidal behaviour in the 
Emergency Department (ED) found that around 40% of patients presenting to hospital with 
self-harm had the capacity to make a decision about their medical treatment and 30% of those 
intended to refuse life-saving treatment.[12] There are few studies that have examined 
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numbers of advance decisions to refuse treatment in patients presenting with suicidal 
behaviour, but in a recent study, three out of 121 fatal cases of self-poisoning in 2005, the 
patients had an advance decision.[13] Given that patient autonomy and advance care 
planning are encouraged in modern healthcare and are assuming greater prominence, it is 
likely that the number of people presenting to hospital with an advance decision following 
suicidal behaviour will grow. 
 
 
Rationale  
 
While reviews of literature relating to the management of advance decisions, both more 
broadly and specifically to relating to “end of life” care exist,[14, 15]  there are currently no 
reviews on the management of advance decisions when a patient presents to hospital 
following suicidal behaviour where the patient does not have a chronic or terminal physical 
illness. Despite the legislative context being similar for end of life care, the ethical 
considerations, emotional challenges and clinical decision-making may be different for 
treatment of a patient following suicidal behaviour without a chronic or terminal physical 
illness. A synthesis of this literature is important to examine similarities and differences and 
to establish the key findings, particularly as the management of advance decisions to refuse 
treatment of injuries and illnesses following suicidal behaviour is challenging for clinicians[8] 
and there is a lack of consistency of practice. A review of the literature will be important to 
inform guidelines for the management of advance decisions following suicidal behaviour. 
 
Aim 
 
To systematically review and synthesise literature on the treatment and clinical management 
of patients presenting to hospital with an advance decision to refuse treatment following 
suicidal behaviour without a chronic or terminal physical illness. The review was conducted 
by researchers in the UK, but an examination of all the existing literature was conducted 
without language or country restrictions.   
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Method 
 
The review was conducted in accordance with PRISMA guidelines[16, 17] and guidance for 
conducting narrative synthesis in healthcare.[18] There is no protocol for the review. We 
used the PRISMA checklist when writing our report.[16]  
 
Search strategy and data sources 
 
An initial scoping of the literature was conducted at inception of the study and the findings 
were used to inform the search strategy. Content experts and clinical practitioners on the 
research team assisted with compiling key words and/or phrases (see Table 1). In order to 
take an inclusive approach and enable inclusion of any papers that involved discussion of 
management of advance decisions following “suicidal behaviour” we included a variety of 
key search terms relating to non-accidental injury and suicidal attempts. An electronic 
search of six databases (EMBASE, MEDLINE, PSYCHINFO, Social Policy and Practice, CINAHL 
and Medline) was conducted, as well as a full electronic search on WestLaw (an online 
library of UK legal information) using the following search terms: advance decisions, 
advance directives AND wills, suicide. Full search strategy for each database is supplied as 
supplementary information (Supplementary Information 1). In addition, the reference 
sections of all included sources were consulted and authors’ personal files were also 
searched to ensure that potentially eligible sources were not omitted. No study design, date 
or language restrictions were imposed.   
 
Literature searches were conducted during the period April 2016 to July 2018. The specific 
inclusion and exclusion criteria are detailed in Table 2.   
 
Study selection 
 
Titles and abstracts were screened, with a random sample of 10% of the articles 
independently screened by another researcher. Additional information was sought where 
there were any disagreements, which were then resolved through discussion. An acceptable 
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concordance rate between the inclusion decisions was predefined as agreement on at least 
90% of the articles, which was achieved for screening on title and abstract. Full text 
screening of the selected articles was conducted by two researchers independently, with full 
agreement being achieved at this stage.   
 
Data extraction and analysis 
 
A preliminary analysis of the data was conducted.[18] Studies were from a range of 
disciplines (i.e. general medical, psychiatry, ethical, legal) and involved reviews of clinical 
cases or fictional scenarios. It was deemed appropriate to conduct a narrative synthesis 
because this particular approach is useful when synthesising textual findings from diverse 
literatures.[18]  Narrative synthesis was conducted in two phases: 1) a textual synthesis, and 
2) an adapted thematic framework analysis.[19]    
 
First, the textual synthesis of the data was conducted by extracting key factual information 
from each study (country of origin, perspective/discipline, factual or fictional case study) 
and details of the case studies (age of patient, mental health conditions, nature of suicidal 
behaviour, resulting injuries/illness, hospital admittance, type of advance decision, when 
advance decision was written, whether patient was conscious, decision-making processes, 
rationale for decision, outcome). The information was then summarised and tabulated to 
map the literature that cited the same clinical case. Information from cases only involving a 
factual case study (i.e. a real clinical case) was extracted because we were interested in 
information about actual clinical cases, decision-making process and rationale for decisions 
made. Thus, information was not extracted from reports that discussed a hypothetical 
scenario for the textual synthesis. Data extraction and summarisation was completed 
independently by two researchers using a pre-determined data extraction sheet.   
 
Second, an adapted thematic framework analysis approach[19] was used to examine key 
themes discussed in the selected papers. This involved five stages: initial open coding, 
indexing, descriptive summaries, charting and tabulation and interpretation. Initial open 
coding generated three general categories representing the most discussed issues across 
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the selected articles: 1) key issues with an advance decision relating to suicidal behaviour, 2) 
challenges in clinical decision-making for advance decisions relating to suicidal behaviour, 
and 3) recommendations for practice. These three categories were used to index the data 
and as a framework to extract and summarise data. Extracted data was then used to form 
descriptive summaries. Indexing, extracting and summarising were conducted 
independently by two researchers. Resulting summaries were compared and discussions 
were held to clarify any differences. Charting and tabulation was conducted by charting the 
summaries by discipline. In order to explore similarities and differences between disciplines, 
we distinguished between “general medical” as papers written from a general medical 
practice or emergency services perspective; “psychiatry” as those written by clinical 
psychiatrists or from a psychiatry perspective, “Nursing” as those written by practising 
nurses or research nurses, “Bioethics” as those in ethics sections in journals or written by 
researchers in medical ethics, “Ethics” as those in ethics journals or written by ethics 
researchers, and “Legal” as those written from a legal perspective and/or by a legal 
representative. Interpretation of the data was conducted by thematic analysis of the 
summary charts to highlight the main recurrent and most important themes.[18] Two 
researchers conducted the thematic analysis independently and then discussed and 
finalised themes. Saturation of the themes was established when no further themes 
emerged and themes could not be further collapsed. “Vote counting” was used to identify 
the frequency with which the themes appeared in the selected papers.[20] In the thematic 
framework analysis all selected studies were included; those involving a factual case and 
those involving a fictional case, because both involved discussions of concerns, challenges 
and rationale for decision making relating to management of an advance decision following 
suicidal behaviour.   
 
Quality assessment 
 
The papers mostly comprised accounts of clinical cases written by clinicians and ethical or 
legal experts. The methodology quality and synthesis of case series and case reports tool 
suggested by Murad and colleagues[21] was used to assess the quality of selected studies.  
Each study was assessed independently across 4 areas of potential bias: selection, 
ascertainment, causality and reporting. The tool consisted of 5 items each requiring a binary 
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response to indicate whether the bias was likely. We considered the quality of the study 
good when all five criteria were fulfilled, moderate when 4 were fulfilled and poor when 3 
or less were fulfilled. The methodological quality of included studies was assessed 
independently by two reviewers and discussion between them where there was 
disagreement.  We also considered the reflexivity of the author/s, their expertise and how 
they were involved in the clinical case (for example as a clinician or legal/ethics consultant). 
Authors of the papers reflected on the management of the clinical case, rationale for 
decision made and issues relating to advance decisions and suicidal behaviour more 
generally.  
 
Patient and Public Involvement 
 
An expert by-experience was a co-applicant on the NIHR Programme Grant and actively 
contributed to the study design and objectives. Patient advisors, carers, and clinicians 
evaluated the relevance and importance of the research questions for the advance decisions 
component of the grant and the systematic review. Our interim and final results were 
presented and evaluated by clinicians, academics, patients, and carers. There was also 
patient input into our dissemination plan, which includes dissemination to clinicians and the 
relevant patient community.  
 
Results 
 
Systematic search  
 
Results of the systematic search are displayed in Figure 1. After removal of duplicates, the 
search returned 634 articles, of which 35 were retained after screening based on 
title/abstract. Following full text screening, 15 articles were retained for data extraction.  
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Study Characteristics 
 
Descriptive information about the selected articles is displayed in Table 3. Five of the 
selected articles were from the UK and the others were from the US (n = 7) or Australia (n = 
3). A total of six clinical cases were reviewed across the 15 articles (see Table 3), as seven 
(47%) of the articles reported the same case (Case A, a well-publicised case of a 26 year old 
woman who died in the UK). Two of the clinical cases presented fictional scenarios.[2, 22] 
 
Study quality assessment 
 
All 15 studies were assessed for bias using the methodology quality and synthesis of case 
series and case reports tool suggested by Murad and colleagues.[21] Nine of the selected 
studies were deemed to have moderate methodologic quality and 6 to have poor quality 
(see supplementary information 2). The quality assessment is supplied as supplementary 
information (Supplementary Information 2). None of the studies reported the 
representativeness or selection process relating to the case report, which impacted on the 
bias ratings. Although case reports are considered to have increased risk of bias, they have 
profoundly influenced medical literature and advance knowledge and their use in reviews is 
considered appropriate where no other higher level evidence is available.[21] 
 
Textual synthesis 
 
Examination of clinical cases discussed in the selected articles 
 
Specific information about clinical cases and decision-making is summarised and charted in 
Table 4. We only included examination of the factual cases (n = 6) in this part of the analysis, 
because we were interested in the types of real-world cases and decisions made, rather 
than an examination of a hypothetical scenario. 
 
Patients discussed in the clinical cases varied in age, ranging from 26-86 years old.  All 
patients were noted as having a diagnosis of depression, some were reported as also having 
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diagnoses of Post-traumatic stress disorder and personality disorders.  The suicide methods 
used in the cases included self-poisoning (n = 3), gunshot incidents (n =2) and hanging (n 
=1). All patients were found by other people, except one patient who called an ambulance 
because they did not want to die alone. Four of the patients were reported to have died; the 
outcome in one case was not specified.  
 
Treatment was provided in only one of the clinical scenarios.[23] In this case, the patient 
was a psychiatric inpatient and the advance decision was considered part of the suicide 
attempt, so the patient’s treatment refusal specified in the advance decision document was 
not adhered to.   
 
The rationale for non-treatment in the clinical cases where the patient died varied and was 
summarised into the following three reasons: 
 
• Advance decision was followed as a legally-binding document after checks showed 
the information was clear and specific, patient was informed of treatment options, 
had mental capacity at the time of writing and family were in agreement with the 
decision for non-treatment (n = 1).[8, 24] 
• Physical injuries were severe resulting in poor prognosis for the patient and the 
treatment refusal in the advance decision was used as evidence that the patient 
would not wish to survive with a life-threatening or severely disabling condition.  
Where possible, families were also consulted (n = 2).[7, 25]   
• Verbal treatment refusal was used as the basis for the treatment decision, rather 
than the advance decision, because the patient was conscious and had mental 
capacity.  Consultation with family was not reported in this case. (n =1).[6, 26, 27, 28-
30, 31] 
 
The decision-making process was reported to take considerable time and legal and/or 
ethical consultation took place in all the reported clinical cases.   
 
Differences in opinions about clinical management and decision-making between 
emergency department clinicians and psychiatric consultants were reported in some of the 
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clinical cases.[23, 25] In those cases, emergency department clinicians gave more weight to 
the advance decision, suggesting it should be adhered to as a legally binding document and 
the patient remain untreated.  In contrast psychiatrists viewed suicide as a consequence of a 
distressed state and expressed a preference to avoid adherence with the advance decision 
and treat the patient. Where such conflict arose this was resolved through consultation with 
the hospital legal team and/or ethics committee. 
 
Thematic analysis 
 
Five themes arose from the thematic analysis and are presented with their corresponding 
sub-themes and vote-counts in Table 5. We included accounts of fictional cases in the 
thematic analysis because here we were interested in opinions, views and perspectives of 
authors. 
 
Themes 
 
1) Tension between patient autonomy and protecting a vulnerable person 
 
Professional dilemma: promoting patient autonomy vs. providing appropriate care 
 
The management of an advance decision in the context of suicidal behaviour was 
particularly challenging because it went against healthcare professionals’ training to 
preserve life (i.e. adherence to the advance decision could result in the death of the patient 
while they could recover if they received treatment for their physical condition). This 
presented clinicians with a dilemma between promoting patients’ autonomy by observing 
their wishes stated in the advance decision and by providing care that was considered in 
their best interests (e.g. promoting life).[7, 23, 26, 28, 30] 
  
 16 
 
Societal expectation to protect vulnerable person and prevent suicide 
 
Authors also raised the issue that clinicians not only had a professional interest in protecting 
a vulnerable person, but there was also a societal expectation that suicide should be 
prevented.[23, 25, 30]  
 
“While the right to autonomy is strong, in some circumstances there may be 
competing rights and interests that are sufficient to override a competent decision 
to refuse treatment. These may include the state’s interests in preventing 
suicide.”[30] 
 
The challenge to clinicians was highlighted by an acknowledgement from some authors that 
adherence to the advance decision in this context was emotive and would feel like assisting 
suicide.[24, 30] 
 
2) Appropriateness of advance decisions for suicidal behaviour 
 
Mental health symptoms and suicidal ideation fluctuate 
 
Concerns were expressed about whether an advance decision should apply in the context of 
suicidal behaviour because of patients’ distressed state, the potential for suicidal ideation to 
fluctuate and for treatment preferences to change in the future.[7, 8, 31, 32]   
 
“The compelling notion that people will change their minds contradicts the primacy 
of patient autonomy in the consideration of suicide. This is what distinguishes an 
impulsive suicide attempt from other informed choices to obtain or refuse medical 
treatment by patients.”[7] 
 
Authors from a psychiatric perspective, in particular, viewed suicidal behaviour as a 
symptom of a mental health condition that was potentially treatable with psychiatric 
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care.[25] They also expressed concerns about the capacity of a distressed suicidal person to 
fully comprehend their decision and consider all treatment options available to them.[2, 24, 
25, 32] Therefore, it was suggested by some authors that a higher level of mental capacity 
may be required at the time of writing the advance decision for clinicians to be confident in 
following it.[8] However, other authors argued that the advance decision should be 
considered as part of the suicide attempt and as evidence of distressed/disordered 
thinking,[8, 23, 27, 28] rather than independently of the attempt, and the treatment refusal 
in the advance decision document should not be adhered to.   
 
Advance decisions for mental and physical health conditions – are they the same? 
 
The difference between an advance decision for suicidal behaviour and for a physical 
condition was highlighted across the selected papers.[6, 32] Authors from a legal 
perspective highlighted that the primary aim of an advance decision relating to a suicide 
attempt is to end life, whereas an advance decision for a chronic or terminal illness is often 
concerned with managing pain and avoiding prolonged suffering.[6]  
 
There was also debate about the extent to which mental suffering legitimised suicide.[32]  
Authors from an ethical perspective argued that, typically, healthcare services may be more 
sympathetic to “end of life” decisions relating to terminal physical health conditions than 
mental health conditions, thus mental health patients do not receive the same palliative 
care options as patients without mental health diagnoses.[24] There was some discussion 
that it should not be assumed that psychiatric pain is more tolerable than physical pain and 
that both should be considered as having a similar influence on the patient.[24, 25]   
 
3) Uncertainty about the application of legislation 
 
Confusion and anxiety about litigation 
 
Authors from general medical and psychiatry perspectives expressed confusion about 
legislation and anxiety about litigation,[2, 23, 30] with one stating that the advance decision 
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document needed to be ‘watertight’ to be considered evidence of the patient’s.[25] Authors 
recommended that clear hospital policies be developed for advance decisions in this 
particular context to overcome the confusion and anxiety about ligation.[23]   
“In addition to the clinical demands associated with treating a patient with a life-
threatening condition, clinicians must do their best to ascertain the patient’s 
capacity for his or her apparent decision, consider the correct ethical course, and 
navigate through uncharted legal waters.”[7] 
 
Authors from the UK and Australia highlighted the difficulties in implementing both mental 
health and mental capacity legislation when managing advance decisions relating to suicidal 
behaviour.[27, 29, 30, 31] Clinicians needed to consider whether someone who had 
attempted suicide was suffering with a mental health condition, for which they should be 
treated against their will. They also needed to judge whether the person had the capacity to 
make a decision about their treatment and, if so, that the advance decision could apply 
following verification checks. Some suggested that application of each legislation model (i.e. 
mental health or mental capacity), in isolation of the other, could result in different 
outcomes for the patient.[6] Some authors suggested that the difficulty with balancing 
mental capacity legislation and mental health legislation could be resolved by developing a 
single legislation that combines both.[8, 27]   
 
Advance decisions are about more than a simple assessment of capacity 
 
A reliance on judging a person’s capacity to make a decision in the context of suicidal 
behaviour was discussed in detail.[8, 22, 24] The capacity assessment was discussed in 
relation to when the patient was involved in advance care planning and making the decision 
to write an advance decision to refuse treatment.[8] Capacity assessment was also 
discussed in relation to clinicians in an emergency situation, when if the person is 
considered to have capacity the advance decision can be ignored and they can verbally 
refuse/accept treatment. While this is an important part of some legislation, particularly in 
the UK, it was suggested that an assessment of capacity should be supplemented with a 
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judgment of the authenticity and durability of the patient’s decision (i.e. if the decision had 
been consistent over time).[22, 26]  Authors from a psychiatric perspective, in particular, 
suggested that advance decisions should be regularly reviewed to ensure that they were up-
to-date and continued to reflect the patient’s desires and preferences.[26, 27, 28] 
 
4) The length of time needed to consider all the evidence vs. rapid decision-making for 
treatment 
 
Need to fully consider the totality of evidence 
 
Some authors suggested that the increased length of time taken in this particular context 
arose from the need to consider contextual factors for the suicidal behaviour,[2, 22, 25] the 
patient’s mental health background[27] and the reason for their decision, alongside the 
usual validation checks and judgment as to presence of mental capacity at the time of 
making the advance decision. It was also argued that clinicians should take into account 
wider factors that may have not been present when the person first wrote the advance 
decision, such as changes in evidence-base for a particular treatment or scientific advances 
offering new treatment options that may influence the patient’s decision.[22]   
 
However, authors highlighted difficulties with gaining access to such evidence, particularly 
in emergency situations, further adding to the time taken to make a decision.[31] It was 
noted that advance decisions were often too specific (e.g. related to a specific illness or 
injury) or too general (e.g. a general refusal of treatment, rather than refusal of a specific 
treatment), resulting in ambiguity as to the best course of action for the patient and time 
consuming investigation.[2,25,28] Some authors highlighted that advance decisions were 
not useful in emergency settings when rapid decision-making was required.[2] Advance 
decisions may be more appropriate for patients to express refusals of on-going psychiatric 
treatment (e.g. Electroconvulsive therapy). 
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 Increased gravity of the clinical decision  
 
Authors argued that the gravity of the clinical decision was increased in this context because 
the patient could die if the advance decision was adhered to when recovery from mental ill 
health may be possible.[6, 25] Authors suggested that validation checks in this context may 
need to be more thorough and authors from a legal perspective argued that, because of the 
increased gravity of the clinical decision, physicians should seek a consensus about clinical 
management, whilst providing life-sustaining treatment, creating a time-consuming 
situation.[7, 31]  
5) Importance of seeking support and sharing the decision  
 
Drawing up an advance decision as a collaborative process 
 
Some authors argued that when writing an advance decision, patients should be supported 
by a healthcare professional to consider all possible treatment options.[2, 22, 23, 27, 29] It 
was suggested that evidence of mental capacity at the time of writing the advance decision 
should be provided (e.g. verified and signed by the healthcare professional) which could 
help with clinical decision-making at a later stage.[22] Authors from all the perspectives 
stressed the importance of also consulting with a physician at the time of writing the 
advance decision to ensure that it is both specific and general enough to be helpful and 
informative in a given medical scenario.[23, 27]   
 
Shared decision making  
 
All authors discussed the need for multi-agency decision-making in relation to the 
management of advance decisions in the context of suicidal behaviour.[7, 27, 28] 
Suggestions included that clinicians should consult widely, make use of psychiatric expertise, 
review the patient’s psychiatric history and background and seek legal and/or ethical 
consultation when considering treatment decisions. 
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Discussion 
 
Summary of the findings 
 
A comprehensive systematic review of studies examining the management of advance 
decisions to refuse treatment following suicidal behaviour was conducted. The findings 
show a paucity of studies in this specific area. Fifteen relevant studies were identified, of 
which all were reports of clinical cases. With the exception of two papers that noted 
fictional clinical cases, the others reported on six real clinical cases. Despite having no 
language or country restrictions to the search, all the studies were from the US, Australia or 
UK, which have similar legislation relating to advance care planning and advance decisions 
to refuse treatment.[2]   
 
There were inconsistent views on practice and rationales for the management of advance 
decisions. Treatment was provided in only one clinical case where the patient was a 
psychiatric inpatient and the advance decision was considered part of the suicide 
attempt.[23] In this case the patient survived and later regretted the suicide attempt. In the 
other clinical cases, treatment was not provided, but rationale for non-treatment differed. 
Rationale for treatment varied from feeling that the advance decision was legally binding[8, 
24] to using the advance decision as an aide to understand the patients’ treatment 
preferences when there was a poor prognosis or a resulting severely disabling condition.[7, 
25]    
 
Conflict between clinicians was reported in some of the reports.[23, 25] In the studies 
where there were conflicts, there were differences in opinions on treatment between 
emergency department clinicians and psychiatrists. Consultations with mental health care 
staff were typically sought when a patient presented with an advance decision following 
suicidal behaviour. Psychiatrists tended to stress the treatable nature of a mental health 
condition and that the suicidal behaviour was part of the mental health condition. In 
contrast, emergency department clinicians argued that the advance decision document was 
legally binding and expressed anxieties about litigation. These differences in opinion about 
treatment were overcome through consultations with legal and ethical representatives. 
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The appropriateness of advance decisions with suicidal behaviour was questioned. The 
questioning of the appropriateness centred largely around two reasons. First, suicide 
ideation was considered to fluctuate and people could change their mind about their desire 
to die.[7, 8, 31, 32] Although suicide has been linked to impulsivity,[33, 34] studies show 
that not all suicides are impulsive.[35]  However, recent studies using ecological momentary 
assessment have shown that suicide ideation varies over short periods of time (i.e. there are 
changes between hours and days)[36] and follow up studies with suicide survivors tend to 
acknowledge that they regret the suicide attempt.[37] Second, outcomes for treatment 
refusal following suicidal behaviour were noted to be potentially different to those for a 
terminal physical health condition (i.e. the patient could die when there is potential for 
recovery in the future). [6, 32]  
 
Authors discussed concerns that management of advance decisions following suicidal 
behaviour may need to be different and present a unique clinical presentation. Similar to 
findings in this review, anxieties and confusion about legislation relating to advance 
decisions is also found in studies examining end of life care.[38] However, what does seem 
to differ is opinions about adherence to the advance decision to refuse treatment for 
chronic or terminal conditions and sympathy for assisted suicide in end of life care. 
Healthcare workers report support for assisted suicide relating to end of life care[39] and 
frustrations with continuing life-sustaining treatment where withdrawing treatment might 
be considered in the best interest of the patient when they have a life-threatening 
condition.[23, 40] Those findings indicate quite a contrast with opinions in this review where 
the focus was on management of advance decisions following suicidal behaviour and an 
expression of sympathy with the decision was not found. It will be important in future 
research to examine these differences further by contrasting views on management of 
advance decisions to refuse treatment following suicidal behaviour for patients with chronic 
and/or terminal physical conditions and patients who have mental health conditions 
without chronic or terminal physical conditions.  
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Management of the advance decision was difficult both emotionally and ethically for some 
clinicians because it challenged their professional training and their desire to protect 
vulnerable patients from suicide. The competing pressures of respecting a patient’s right to 
autonomy while protecting them from the effects of mental disorder found in the current 
study are a commonly reported dilemma.[41] There is evidence from the present study that 
support for the right to autonomy may be more dominant in clinicians from emergency 
medicine disciplines, with those from a psychiatric background prioritising prevention of 
suicide. A ‘middle ground’ between these views may help to provide guidance for clinicians. 
For example, in English law, courts have acknowledged that while some suicidal individuals 
may have capacity, the overwhelming likelihood is that capacity is impaired to at least some 
degree.[41] Suicidal ideation has been associated with disordered and impulsive decision 
making[33, 34] and evidence indicates that most mental health patients presenting to 
emergency departments are judged as not having capacity to make a treatment 
decision.[12]Therefore a higher degree of certainty should be required when assessing 
capacity with suicidal behaviour and clinicians should err on the side of caution .[8] Another 
potential resolution to this dilemma, particularly in emergency scenarios, may be to provide 
‘temporary intervention’ to allow time for individuals to be assessed and treatment options 
to be discussed.[41] 
 
An added pressure for clinicians in the management of advance decisions following suicidal 
behaviour was that they felt there was a societal expectation that suicide should be 
prevented. Adhering with the advance decision made by the patient by not treating them, 
not only was seen to go against their professional training to protect the patient, but it was 
viewed that this may be considered from a society perspective as unacceptable. The 
dilemma here is that a clinical decision of non-treatment and adherence with the advance 
decision might be accepted legally, but not socially. Concerns were expressed that this 
particular presentation of an advance decision met conditions that warranted overriding 
patients’ autonomy because non-adherence with the advance decisions results in 
prevention of suicide, maintenance of the integrity of the medical professional and 
preservation of life.[25] 
  
 24 
Recommendations for practice 
 
Decisions made about advance decisions in the context of suicidal behaviour should be 
made in full consultation with psychiatric teams and with relevant legal and/or ethical 
advisers. The results also highlight the importance of allocating sufficient time to consider 
contextual evidence relating to the suicidal behaviour, the authenticity of the treatment 
decision and verification of the documentation/decision. Given the gravity and emotive 
nature of a decision in this context, emergency healthcare workers may need increased 
support and supervision for such incidents.  
 
Findings indicate that it may be helpful, in this particular context, for an advance decision to 
be written in consultation with a professional healthcare worker and the patient’s family. 
This practice would also ensure that the patient is supported to consider all treatment 
options, that the advance decision is specific and detailed enough to be useful in an 
emergency situation and that patients’ capacity at the time of writing the advance decision 
can be assessed and verified. The advance decision should be regularly reviewed and 
updated to ensure that it reflects the patient’s current treatment decisions. 
 
Strengths and Limitations 
 
A strength of this review is that a broad range of articles from different disciplines were 
included, thus increasing the generalisability of results.  However, there were some 
potential biases in the literature.  First, there was a paucity of evidence: only six clinical 
cases were reported across the selected articles.  There was also a risk of bias from the 
studies themselves, given that they were reviews of single clinical cases.  Second, the 
articles were focussed on the US, UK and Australia, so may have resulted in bias relating to 
the specific legislation/ethics of those countries.  There may be different views on this topic 
and its management in countries with different implementation of legislation, so it will be 
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important for future research to compare findings internationally across a wider range of 
countries.[42-44] Third, as with any syntheses of qualitative data there was potential for 
bias to be introduced by the research team at the stages of study identification, data 
extraction and synthesis. This was minimised in the current study by having two researchers 
carry out these tasks independently and cross-check the findings. 
 
Future directions 
 
Empirical studies, such as interviews and focus groups with clinicians and patients and/or a 
national clinical survey are important future priorities. Given that the presentation of an 
advance decision following suicidal behaviour is rare, case reports are likely to continue to 
be important sources of information in the future and authors should be mindful to ensure 
that case reports include details about how information about the case were obtained and 
how representative it is of other cases in this area. Research examining the prevalence of 
advance decisions relating to suicidal behaviour could shed light on the frequency of such 
presentations.  Suitable platforms for storing advance decisions could also be explored. For 
example, some have suggested a web application (‘app’) could better reflect the dynamic 
nature of treatment refusal[45] and make updating and reassessment easier.  
 
Conclusion 
 
Current literature on the management of advance decisions and suicidal behaviour centres 
on detailed accounts of clinical cases and demonstrates variability in practice and the 
rationale behind clinical decisions. Challenges in managing advance decisions specific to 
suicidal behaviour were evident and there was some debate about whether advance 
decisions in the context of suicidal behaviour were appropriate in their current form. Taking 
time to consider all the evidence when making a decision, consulting fully with mental 
health clinicians and seeking legal and/or ethical advice may help with some of these 
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challenges. The support of a relevant healthcare professional at the time of writing the 
advance decision may also be useful.   
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Table 1. Search terms for each topic 
Advance directives OR Mental capacity AND Suicidal behaviour 
advance decisions  
advance directives 
advance statement 
living will(s) 
mental health directive 
Ulysses contract(s)  
psychiatric will(s) 
antecedent decision/wish 
pre-emptive suicide 
antecedent refusal 
resuscitation order 
health care power of 
attorney 
 mental 
competency 
mental capacity 
 
 Suicide 
attempted suicide 
self-mutilation 
self-harm 
deliberate self-harm 
parasuicide 
self-injurious behaviour 
drug overdose 
self-immolation 
self-poisoning 
self-destructive 
behaviour 
auto aggression 
automutilation 
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Table 2. PICOS criteria for inclusion and exclusion 
Parameter Inclusion criteria Exclusion criteria 
Patients Patients over 18 years who 
present to hospital with 
advance decisions* (also 
include Do Not Resuscitate 
orders, DNRs) following suicidal 
behaviour (including attempted 
suicide, deliberate self-harm, 
self-injurious behaviour, drug 
overdose, self-poisoning, self-
destructive behaviour) with no 
existing chronic or terminal 
physical conditions 
 
Patients who present to 
hospital with advance 
decisions but with primary 
conditions which were not 
mental health related e.g. 
HIV/AIDS, chronic physical 
health conditions or 
disabilities, 
neurodegenerative diseases 
and/or specific patient 
groups e.g. mother/baby. 
 
Intervention medical management and/or 
medico legal and/or ethical 
consultation/discussion  
medical management of 
euthanasia, assisted suicide, 
end of life, wills/inheritance 
(i.e. monetary or property 
issues) 
 
 
Comparator 
 
  
Outcomes Adherence/non-adherence 
with advance decision, 
treatment, patient outcome 
(i.e. death) 
 
 
Study design Opinion and review articles, 
Case studies, Empirical 
studies/surveys 
Book reviews, Reponses to 
articles, conference 
abstracts 
* or other terms such as advance decisions, advance directives, advance statement, living 
will(s), mental health directive, Ulysses contract(s), psychiatric will(s), mental competency, 
mental capacity, health care power of attorney, antecedent decision/wish, pre-emptive 
suicide, antecedent refusal, resuscitation order or living will, advance directive, Ulysses 
contract  
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Table 3. Description of selected studies 
 
Author Date 
 
Country Perspective# 
Fictional/ 
Factual case  
Case 
reported* 
Bryne[2]  2002 Australia Nursing Fictional -- 
Callaghan & Ryan[26] 2011 Australia Bioethics Factual A 
Chalfin et al[25] 2001 US, Philadelphia, New 
York, New Zealand 
Emergency & 
Acute medicine/ 
Bioethics 
Factual B 
Cook et al[23] 2010 US, Illinois Psychiatry Factual C 
Dresser[6] 2010 US, New York Legal Factual A 
David et al[27] 2010 UK Psychiatry Factual A 
Frank[7] 2013 US, Colorado Legal Factual D 
Kapur et al[8] 2010 UK Psychiatry Factual E 
Mitchell[22] 2011 US, San Diego Ethical Fictional -- 
Muzaffer[28] 2011 UK Psychiatry Factual A 
Richardson[29] 2013 UK Legal Factual A 
Ryan & Callaghan[30] 2010 Australia Psychiatry Factual A 
Sontheimer[24] 2008 US, Springfield Bioethics Factual E 
Szawarski[31] 2013 UK Bioethics Factual  A 
Volpe et al[32] 2012 US, New York Bioethics Factual F 
Note:  *For specific details about each case see Table 4, note fictional cases have not been given a case report ID 
 #where the perspective is not clearly stated this has been derived from the author(s) background and professional experience 
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Table 4. Description of clinical cases discussed in selected studies  
Case  Reference Age Mental 
health 
conditions 
Nature of 
SA 
Resulting 
Injuries/ 
illness  
Hospital 
admittance 
Nature 
of the 
AD 
When 
written? 
Patient 
conscious
? 
Decision Making process Rationale for decision  Outcome 
A 6, 26, 27, 
28-30, 31 
 
26 Depression 
generalised 
anxiety 
disorder, 
PTSD, BPD 
Self-
poisoning 
(anti-
freeze) 
Not stated Presented 
herself at 
hospital 
Letter 3 days prior Yes  Medical staff discussed the patient’s 
mental capacity and sought legal 
advice. 
The patient’s wishes were 
clear in the letter but the 
patient was conscious, 
judged to have capacity 
and refusing treatment. 
Death 
B 25 46 Severe 
depression  
Gunshot 
to face 
Pain and 
severe facial 
injury 
Gunshot 
reported by 
neighbours 
Suicide 
note 
not stated Yes (not 
coherent) 
The attending physicians thought life-
support should be removed as the 
patient’s “will” was clear and 
authoritative. The psychiatrist 
thought suicide was pathological and 
the condition was treatable so the 
patient should be treated. Clinicians 
consulted widely and sought legal 
advice 
The suicide note was 
accepted as a living will. 
The patient had a desire 
to die due to 
psychological pain. The 
suicide attempt left the 
patient in a severely 
disabled state.  
Death 
C 23 57 Depression 
generalised 
anxiety 
disorder, 
PTSD, BPD 
Self-
poisoning 
(opiates) 
Respiratory 
distress 
Psychiatric 
inpatient 
DNR Prior to 
inpatient 
admittance 
Not stated There was conflict between 
clinicians; the psychiatrist argued 
that the DNR should not be followed 
because it was a suicide attempt. The 
legal/ethics committee was 
consulted who supported continued 
treatment.   
DNR considered an effort 
to prepare for a suicide 
attempt and should not 
be honoured. 
Survived 
and 
regretted 
the 
suicide 
attempt. 
D 7 35 Depression 
and drug 
abuse 
Hanging  Brain injury Found by 
family  
AD Not stated No There were concerns that adherence 
to the AD would result in the 
patient’s death. Clinicians sought 
legal advice. 
The patient had poor 
prognosis and the family 
gave consent for 
clinicians to stop 
treatment. 
Death 
E 8, 24 52 Depression 
generalised 
anxiety 
disorder, 
PTSD, BPD 
Self-
poisoning 
(insulin) 
Coma Found at 
home 
AD 2 years 
prior 
No The AD mentioned no treatment for 
a terminal condition. The patient was 
not in a terminal condition and there 
were concerns that injury was the 
result of a suicide attempt and 
whether the AD should be adhered 
to in a suicidal context.  Approached 
family and held an ethics committee 
consultation.   
The patient’s wishes were 
judged to be clear, the 
patient was considered to 
be informed about 
treatment options and 
had mental capacity at 
the time of writing the AD 
and the family were in 
agreement. 
Death 
F 32 86 Not stated Gunshot 
to chest 
Damage to 
pancreas 
and colon 
Not stated AD Not stated Yes (not 
always 
coherent) 
Medical team argue that the nature 
in which the physical condition was 
caused (i.e. suicidal behaviour) 
should impact on treatment 
Not stated Not stated 
Note: *for details about articles see Table 3, SA = suicide attempt, AD = advance directive, PTSD = post-traumatic stress disorder, BPD = borderline personality disorder 
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Table 5. Themes from the selected articles 
Theme Sub-themes Theme Descriptor Perspectives References Count % 
Tension between 
patient autonomy 
and protecting a 
vulnerable person 
 
Professional dilemma: promoting patient 
autonomy vs. providing appropriate care 
 
Societal expectation to protect vulnerable 
person and prevent suicide 
Tension between acting in accordance with patients’ wishes for their 
medical treatment while promoting their best interests presented 
clinicians with a professional ethical dilemma.  Clinicians also had a 
personal ethical dilemma, as there is societal pressure to protect 
vulnerable people and prevent suicide. 
Psychiatry, 
Bioethics, 
Legal 
7, 22, 24, 
27, 29 
5 (33%) 
Appropriateness of 
advance decisions for 
suicidal behaviour  
Mental health symptoms and suicidal ideation 
fluctuate 
 
Advance decisions for mental and physical 
health conditions – are they the same? 
There were questions about whether an advance decision “fits” in 
relation to suicide without an existing physical illness because 
mental state, mental health and suicide ideation fluctuate. Such 
scenarios are different from decisions made about treatment for a 
chronic or terminal physical condition. 
 
Medical, 
Psychiatry, 
Bioethics, 
Legal 
2, 6-8, 
23-25, 
27, 29-32 
12 (80%) 
Uncertainty about 
the application of 
legislation  
Confusion and anxiety about litigation 
 
Advance decisions are about more than a 
simple assessment of capacity 
Legislation around advance decisions was seen as confusing and 
there was anxiety about ligation. It was noted that mental capacity 
legislation overlapped with mental health legislation and policy.  
There were concerns that relying on a capacity decision was not 
sufficient and the authenticity of the advance decision needed to be 
considered 
Medical, 
Psychiatry, 
Bioethics, 
Legal  
2, 8, 22-29, 
31 
11 (73%) 
The length of time 
needed to consider 
all the evidence vs. 
rapid decision-
making for treatment 
Need to fully consider the totality of evidence 
 
Increased gravity of the clinical decision  
Clinical decisions were considered to be complex, involving an 
assessment of mental capacity, verification of the advance decision, 
and consideration of contextual factors. Therefore sufficient time 
was needed in which to consider all of the evidence. 
Medical, 
Psychiatry, 
Bioethics 
Legal 
2, 8, 25-27 5 (33%) 
Importance of 
seeking support and 
sharing the decision  
Drawing up an advance decision as a 
collaborative process 
 
Shared decision making  
Sharing the decision-making and seeking support, both at the time 
of writing the advance decision and when treating the patient, was 
viewed as important.   
Medical, 
Psychiatry, 
Bioethics, 
Legal 
2, 7, 24-28, 
30, 31 
9 (60%) 
 
  
 35 
Figure 1. Flow chart of results from initial search 
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database searching 
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through other sources 
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Records after duplicates removed  
(n = 634) 
Titles/abstracts 
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(n = 634) 
Full-text articles 
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(n = 35)   
)) 
Studies included in the 
synthesis  
(n = 15) 
Full-text articles 
excluded, with reasons 
(n = 20) 
1 x response to article only 
5 x physical illness only 
5 x not relating to suicide 
1 x AD not mentioned 
 1 x wills and inheritance 
2 x neurodegenerative diseases 
5 x treatment refusal 
